Search

Your search keyword '"Laurens, Matthew B."' showing total 375 results

Search Constraints

Start Over You searched for: Author "Laurens, Matthew B." Remove constraint Author: "Laurens, Matthew B."
375 results on '"Laurens, Matthew B."'

Search Results

1. Gene expression analyses reveal differences in children’s response to malaria according to their age

4. Risk of COVID-19 after natural infection or vaccination

5. Children with hemoglobin C or S trait have low serologic responses to a subset of malaria variant surface antigens

6. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

7. Efficacy of typhoid conjugate vaccine: final analysis of a 4-year, phase 3, randomised controlled trial in Malawian children

10. Malaria Vaccines

11. Immunoprofiles associated with controlled human malaria infection and naturally acquired immunity identify a shared IgA pre-erythrocytic immunoproteome

12. Risk of COVID-19 after natural infection or vaccination

15. Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination

16. Serologic responses to the PfEMP1 DBL-CIDR head structure may be a better indicator of malaria exposure than those to the DBL-α tag

17. Antibodies to Peptides in Semiconserved Domains of RIFINs and STEVORs Correlate with Malaria Exposure

18. Safety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trial

19. PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial

20. Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi: a nested substudy of a double-blind, randomised controlled trial

21. Children with cerebral malaria or severe malarial anaemia lack immunity to distinct variant surface antigen subsets

22. Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial

23. Safety and immunogenicity of co-administration of meningococcal type A and measles–rubella vaccines with typhoid conjugate vaccine in children aged 15–23 months in Burkina Faso

26. High burden of malaria among Malawian adults on antiretroviral therapy after discontinuing prophylaxis

27. Recombinant Full-length Plasmodium falciparum Circumsporozoite Protein–Based Vaccine Adjuvanted With Glucopyranosyl Lipid A–Liposome Quillaja saponaria 21: Results of Phase 1 Testing With Malaria Challenge

28. Dose-Dependent Infectivity of Aseptic, Purified, Cryopreserved Plasmodium falciparum 7G8 Sporozoites in Malaria-Naive Adults

29. Typhoid Vaccine Acceleration Consortium Malawi : A Phase III, Randomized, Double-blind, Controlled Trial of the Clinical Efficacy of Typhoid Conjugate Vaccine Among Children in Blantyre, Malawi

32. A new landscape for malaria vaccine development.

34. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection

35. Gene expression analyses reveal differences in children's response to malaria according to their age

36. Natural immunity to malaria preferentially targets the endothelial protein C receptor-binding regions of PfEMP1s

37. Risk of COVID-19 after natural infection or vaccination

39. Durable anti-Vi IgG and IgA antibody responses in 15-month-old children vaccinated with typhoid conjugate vaccine in Burkina Faso

42. Immunogenomic profile at baseline predicts host susceptibility to clinical malaria

43. Strain-specific Plasmodium falciparum multifunctional CD4+ T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate

44. Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02A

46. Hemoglobin C Trait Provides Protection From Clinical Falciparum Malaria in Malian Children

48. Malian children infected with Plasmodium ovale and Plasmodium falciparum display very similar gene expression profiles

49. A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malaria

50. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

Catalog

Books, media, physical & digital resources